102 / 102
Dyna Indapamide SR.
Each sustained release tablet contains 1,5 mg indapamide. Reg. No.: RSA S3 A42/7.1/0790. NAM NS2 12/7.1/0138. For full prescribing information, refer to the package insert approved by the
Medicines Control Council, 25 November 2011.
1)
Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drug Safety 2001;24(15):1155-1165.
2)
Department of Health website.
http://
www.mpr.gov.za– Accessed 06/06/2016.
DIND223/07/2016.
For further product information contact
PHARMA DYNAMICS
P O Box 30958 Tokai Cape Town 7966
Tel
021 707 7000
Fax
021 701 5898
CUSTOMER CARE LINE
0860 PHARMA (742 762)
www.pharmadynamics.co.zaSUSTAINED
RELEASE
METABOLICALLY
NEUTRAL
1
A Lupin Group Company
only generic
1,5 mg
sustained release
formulation
R33
,19
2
Printed by Tandym Printers